norleucine has been researched along with Cognition Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, J; Chao, W; Dash, RP; Hadas, E; Kamiya, A; Kelschenbach, J; Kim, BH; Lovell, LE; Manning, AA; Nedelcovych, MT; Prchalová, E; Rais, R; Slusher, BS; Thomas, AG; Volsky, DJ; Wu, Y; Zhu, X | 1 |
1 other study(ies) available for norleucine and Cognition Disorders
| Article | Year |
|---|---|
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.
Topics: AIDS Dementia Complex; Animals; Azo Compounds; Caproates; CD11b Antigen; Cognition Disorders; Conditioning, Classical; Fear; Glutamates; Glutamine; HIV-1; Leukemia Virus, Murine; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred C57BL; Microglia; Norleucine; Prodrugs; Reassortant Viruses; Spatial Learning | 2019 |